Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Income from Non-Controlling Interests (2020 - 2025)

Historic Income from Non-Controlling Interests for ImmunityBio (IBRX) over the last 6 years, with Q3 2025 value amounting to -$21000.0.

  • ImmunityBio's Income from Non-Controlling Interests rose 869.57% to -$21000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$77000.0, marking a year-over-year increase of 1046.51%. This contributed to the annual value of -$81000.0 for FY2024, which is 8765.24% up from last year.
  • According to the latest figures from Q3 2025, ImmunityBio's Income from Non-Controlling Interests is -$21000.0, which was up 869.57% from -$19000.0 recorded in Q2 2025.
  • ImmunityBio's Income from Non-Controlling Interests' 5-year high stood at -$17000.0 during Q4 2024, with a 5-year trough of -$1.1 million in Q2 2021.
  • Over the past 5 years, ImmunityBio's median Income from Non-Controlling Interests value was -$111000.0 (recorded in 2022), while the average stood at -$242526.3.
  • As far as peak fluctuations go, ImmunityBio's Income from Non-Controlling Interests tumbled by 12287.92% in 2021, and later soared by 9401.2% in 2024.
  • ImmunityBio's Income from Non-Controlling Interests (Quarter) stood at -$294000.0 in 2021, then skyrocketed by 62.24% to -$111000.0 in 2022, then soared by 80.18% to -$22000.0 in 2023, then grew by 22.73% to -$17000.0 in 2024, then decreased by 23.53% to -$21000.0 in 2025.
  • Its Income from Non-Controlling Interests stands at -$21000.0 for Q3 2025, versus -$19000.0 for Q2 2025 and -$20000.0 for Q1 2025.